Article
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region.
Hepatology (Baltimore, Md.) - 1 Mar 2001
Stuyver L J, Locarnini S A, Lok A, Richman D D, Carman W F, Dienstag J L, Schinazi R F
Abstract excerpt
There is currently no universally accepted numbering convention for the antiviral drug-related resistance mutations in the reverse transcriptase (rt) domain of the human hepatitis B virus (HBV) polymerase. The published inconsistencies have resulted from different HBV genotypes. A standardized nu...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
